NeoGenomics Dividend
Dividend criteria checks 0/6
NeoGenomics hat in der Vergangenheit keine Dividende gezahlt.
Key information
n/a
Dividend yield
n/a
Payout ratio
Industry average yield | 1.7% |
Next dividend pay date | n/a |
Ex dividend date | n/a |
Dividend per share | n/a |
Earnings per share | -US$0.69 |
Dividend yield forecast in 3Y | 0% |
Recent dividend updates
No updates
Recent updates
Investors Interested In NeoGenomics, Inc.'s (NASDAQ:NEO) Revenues
Mar 30Investor Optimism Abounds NeoGenomics, Inc. (NASDAQ:NEO) But Growth Is Lacking
Dec 26Is NeoGenomics (NASDAQ:NEO) A Risky Investment?
Aug 23Risks To Shareholder Returns Are Elevated At These Prices For NeoGenomics, Inc. (NASDAQ:NEO)
Jul 16NeoGenomics (NASDAQ:NEO) Is Making Moderate Use Of Debt
Apr 18We Think NeoGenomics (NASDAQ:NEO) Has A Fair Chunk Of Debt
Jan 10NeoGenomics: Market Punishment Continues, But Looks Justified
Sep 30NeoGenomics grants CEO restricted shares, stock options
Aug 17Here's Why NeoGenomics (NASDAQ:NEO) Can Afford Some Debt
Aug 10NeoGenomics rises ~14% on strong Q2 result
Aug 09NeoGenomics gets new CEO
Jul 21NeoGenomics: Refrain From Portfolio Allocation, Negligible Upside Potential
Jun 28Is NeoGenomics (NASDAQ:NEO) Using Too Much Debt?
Apr 22Neogenomics: Poor Performance, CEO Departure Create Downward Share Price Spiral
Apr 08Why NeoGenomics, Inc. (NASDAQ:NEO) Could Be Worth Watching
Feb 11Is NeoGenomics (NASDAQ:NEO) Weighed On By Its Debt Load?
Jan 07NeoGenomics: Gambling On Growth
Dec 16NeoGenomics: Profitability Headwinds Compress Valuation, Shares
Sep 28Is NeoGenomics (NASDAQ:NEO) Using Too Much Debt?
Sep 24NeoGenomics: Strong Growth Potential For A Leader In Cancer Diagnostic Testing
Jul 02NeoGenomics completes Inivata acquisition
Jun 18Stability and Growth of Payments
Fetching dividends data
Stabile Dividende: Es liegen keine ausreichenden Daten vor, um festzustellen, ob die Dividende je Aktie von NEO in der Vergangenheit stabil geblieben ist.
Wachsende Dividende: Unzureichende Daten, um festzustellen, ob die Dividendenzahlungen von NEO gestiegen sind.
Dividend Yield vs Market
NeoGenomics Dividend Yield vs Market |
---|
Segment | Dividend Yield |
---|---|
Company (NEO) | n/a |
Market Bottom 25% (US) | 1.5% |
Market Top 25% (US) | 4.7% |
Industry Average (Healthcare) | 1.7% |
Analyst forecast in 3 Years (NEO) | 0% |
Bemerkenswerte Dividende: Es ist nicht möglich, die Dividendenrendite von NEO im Vergleich zu den unteren 25 % der Dividendenzahler zu bewerten, da das Unternehmen keine aktuellen Ausschüttungen gemeldet hat.
Hohe Dividende: Es ist nicht möglich, die Dividendenrendite von NEO im Vergleich zu den besten 25 % der Dividendenzahler zu bewerten, da das Unternehmen keine aktuellen Ausschüttungen gemeldet hat.
Earnings Payout to Shareholders
Abdeckung der Erträge: Unzureichende Daten zur Berechnung der Ausschüttungsquote von NEO, um festzustellen, ob die Dividendenzahlungen durch die Gewinne gedeckt sind.
Cash Payout to Shareholders
Cashflow-Deckung: Es ist nicht möglich, die Nachhaltigkeit der Dividende zu berechnen, da NEO keine Ausschüttungen gemeldet hat.